Overview

Study of GBT021601 in Participants With Renal Impairment

Status:
Not yet recruiting
Trial end date:
2024-07-15
Target enrollment:
Participant gender:
Summary
Renal Impairment study of GBT021601.
Phase:
Phase 1
Details
Lead Sponsor:
Global Blood Therapeutics
Collaborator:
Pfizer